Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 97
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment 2024 Buldini, BarbaraVarotto, ElenaScarparo, PamelaBiffi, Alessandra + BLOOD - -
Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion 2023 Tretti Parenzan, CaterinaDal Molin, AnnaLongo, GiorgiaGaffo, EnricoBuratin, AlessiaSerafin, ValentinaBiondi, AndreaBuldini, BarbaraBresolin, SilviaBortoluzzi, Stefania + BLOOD ADVANCES - -
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia 2023 Bresolin, SilviaBuldini, Barbara + HEMASPHERE - -
TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis 2023 Buldini, Barbara + BLOOD - -
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials 2023 Buldini, Barbara + JOURNAL OF CLINICAL ONCOLOGY - -
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 2023 Buldini, Barbara + JOURNAL OF CLINICAL ONCOLOGY - -
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group 2023 Buldini, Barbara + JOURNAL OF CLINICAL ONCOLOGY - -
Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial 2023 Buldini, Barbara + JOURNAL OF CLINICAL ONCOLOGY - -
CD72 is a pan-tumor antigen associated to pediatric acute leukemia 2023 Buldini B.Faggin G.Scarparo P.Polato K.Tregnago C.Varotto E.Biffi A.Pigazzi M. + CYTOMETRY. PART A - -
FCM marker importance for MRD assessment in T-Cell Acute Lymphoblastic Leukemia: An AIEOP-BFM-ALL-FLOW Study Group Report 2023 Faggin, GiovanniBuldini, Barbara + CYTOMETRY. PART A - -
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus 2023 Urso, LoredanaRaimondi, VittoriaBuldini, BarbaraMinuzzo, Sonia A.D’Agostino, Donna M.Ciminale, Vincenzo + ANTIOXIDANTS - -
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement 2023 Buldini, Barbara + HAEMATOLOGICA - -
Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system 2023 Tretti Parenzan, CaterinaRampazzo, ElenaScarparo, PamelaCaicci, FedericoBarbieri, VitoRosato, AntonioPigazzi, MartinaBiffi, AlessandraBuldini, BarbaraPersano, LucaBresolin, Silvia + BLOOD ADVANCES - -
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia 2022 Veltri, GiuliaLovisa, FedericaCortese, GiulianaCarraro, ElisaFrancescato, SamuelaBiffi, AlessandraBuldini, BarbaraSerafin, ValentinaMussolin, Lara + FRONTIERS IN ONCOLOGY - -
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia 2022 Serafin, ValentinaBuldini, BarbaraBasso, Giuseppe + SCIENCE ADVANCES - -
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high???risk first relapse B???cell precursor acute lymphoblastic leukemia 2022 Barbara Buldini + PEDIATRIC BLOOD & CANCER - -
FLT3‐ITD in Children with Early T‐cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 2022 Buldini B.Silvestri D. + CANCERS - -
Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies 2022 Buldini B. + EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY - -
NUP214-ABL1 fusion in childhood T-ALL 2022 Veltri, GiuliaSandei, MaxBresolin, SilviaBiffi, AlessandraBuldini, BarbaraAccordi, BenedettaSerafin, Valentina + PEDIATRIC BLOOD & CANCER - -
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 2022 Bresolin, SilviaVendramini, ElenaBuldini, BarbaraBiondi, Andrea + EBIOMEDICINE - -
Mostrati risultati da 1 a 20 di 97
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile